Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1182/blood.2020006028 http://scihub22266oqcxt.onion/10.1182/blood.2020006028 32275740!7243146!32275740     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32275740&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Blood 2020 ; 135 (21): 1829-1832 Nephropedia Template TP {{tp|p=32275740|t=2020. ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic |pdf=|usr=}}{{32275740}} gab.com Text ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic JO: Blood http://www.kidney.de/pget.php?&tw=1&pmid=32275740 #FOAvip The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed. Twit Text FOAVip ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic ????Blood http://www.kidney.de/pget.php?&tw=1&pmid=32275740 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32275740 #FOAvip English Wikipedia <ref>{{Cite pmid|32275740}}</ref> ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic #MMPMID32275740 Yahalom J; Dabaja BS; Ricardi U; Ng A; Mikhaeel NG; Vogelius IR; Illidge T; Qi S; Wirth A; Specht L Blood 2020[May]; 135 (21): 1829-1832 PMID32275740show ga The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed. |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology/prevention & control[MESH] |Hematologic Neoplasms/*radiotherapy[MESH] |Humans[MESH] |Lymphoma/*radiotherapy[MESH] |Pandemics/prevention & control[MESH] |Pneumonia, Viral/*epidemiology/prevention & control[MESH] |Radiotherapy Dosage[MESH] |Radiotherapy Planning, Computer-Assisted[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]ILROG emergency guidelines for radiation therapy of hematological mali(epmc).pdf DeepDyve Pubget Overpricing